FISPB
EW icon

Fideuram - Intesa Sanpaolo Private Banking’s Edwards Lifesciences EW Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Buy
138,960
+127,713
+1,136% +$10.7M 0.38% 71
2026
Q1 		$901K Sell
11,247
-7,826
-41% -$645K 0.03% 299
2025
Q4 		$1.63M Buy
+19,073
New +$1.57M 0.06% 240

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's EW Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking increased its Edwards Lifesciences (EW) stake by 1,136% in Q2 2026, buying an estimated $10.7M and bringing the position to 138,960 shares worth $12.6M. The position accounts for 0.38% of the portfolio, ranked #71.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 138,960 shares of Edwards Lifesciences worth $12.6M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking bought 127,713 Edwards Lifesciences shares in Q2 2026, an estimated $10.7M.
  • Edwards Lifesciences made up 0.38% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #71 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.